Clinical Trial Update: Meta-analyses of Fructose and Cardiometabolic Risk

View source ↗

Summary

This document provides an update on meta-analyses examining the relationship between fructose intake and cardiometabolic risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Dyslipidemia
• Hypertension
• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease
• Obesity
• Overweight

Snippet

Sponsor: John Sievenpiper | Conditions: Dyslipidemia, Diabetes | Status: UNKNOWN